XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.1
Equity and Long-term Investments and Fair Value Measurements - Equity Investment in Armata (Details) - Armata
$ / shares in Units, $ in Millions
3 Months Ended
Jan. 10, 2023
USD ($)
$ / shares
Feb. 09, 2022
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
Tranche
Director
Mar. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
shares
Mar. 31, 2021
USD ($)
shares
Mar. 31, 2020
USD ($)
shares
Dec. 31, 2022
USD ($)
Equity investment                
Number of tranches | Tranche     2          
Percentage of maximum voting rights   49.50% 49.50%          
Number of Investee's Board members currently representing the Company | Director     3          
Number of the Investee's Board members | Director     8          
Special terms on re-designating board member to board of investee   In addition, as of February 9, 2022, Armata entered into an amended and restated investor rights agreement with the Company and ISO, pursuant to which for as long as the Company and ISO hold at least 12.5% of the outstanding shares of Armata’s common stock on a fully-diluted, the Company and ISO shall have the right to designate two directors to Armata’s board of directors, and for so long as the Company and ISO hold at least 8%, but less than 12.5%, of the outstanding shares of Armata’s common stock on a fully-diluted basis, the Company and ISO shall have the right to designate one director to Armata’s board of directors, subject to certain conditions and qualifications set forth in the amended and restated investor rights agreement.            
Consolidated Investees                
Equity investment                
Equity method investment ownership percentage     69.40%         69.40%
Two Directors                
Equity investment                
Armata outstanding shares percentage   12.50%            
Secured Convertible Credit Agreement                
Equity investment                
Debt instrument, description On January 10, 2023, we entered into a Secured Convertible Credit Agreement (the “Credit Agreement”) with Armata, under which we extended a one-year convertible note (the "Armata Convertible Note") in an aggregate amount of $30.0 million at an interest rate of 8.0% per annum.              
Term loan facility in aggregate amount $ 30.0              
Debt Instrument, annual interest rate 8.00%              
Debt instrument, term 1 year              
Common stock and warrants                
Equity investment                
Amount of securities purchase agreement             $ 25.0  
Unrealized loss       $ 4.2        
Unrealized gain     $ 15.8          
Warrants purchased in 2020                
Equity investment                
Number of warrants purchased under the securities purchase agreement | shares             8,710,800  
Exercise price of warrants | $ / shares $ 2.87              
Term of warrants 5 years              
Warrants purchased in 2021                
Equity investment                
Exercise price of warrants | $ / shares $ 3.25              
Term of warrants 5 years              
Warrants purchased in 2022                
Equity investment                
Exercise price of warrants | $ / shares $ 5.00              
Term of warrants 5 years              
Warrants                
Equity investment                
Equity method investments at fair value     13.1         $ 8.1
Common stock                
Equity investment                
Number of shares to be purchased under the securities purchase agreement | shares             8,710,800  
Equity method investments at fair value     41.9         $ 31.1
Armata Convertible Note                
Equity investment                
Equity method investments at fair value     32.8          
Unrealized gain     $ 2.8          
Minimum [Member] | One Director                
Equity investment                
Armata outstanding shares percentage   8.00%            
Maximum [Member] | One Director                
Equity investment                
Armata outstanding shares percentage   12.50%            
Innoviva Strategic Opportunities, LLC | Common stock and warrants                
Equity investment                
Amount of securities purchase agreement   $ 45.0       $ 20.0    
Innoviva Strategic Opportunities, LLC | Warrants                
Equity investment                
Number of warrants to be purchased under the securities purchase agreement | shares   4,500,000       6,153,847    
Exercise price of warrants | $ / shares   $ 5.00            
Innoviva Strategic Opportunities, LLC | Common stock                
Equity investment                
Number of shares to be purchased under the securities purchase agreement | shares         1,212,122      
Number of shares to be purchased under the securities purchase agreement | shares   9,000,000            
Number of warrants to be purchased under the securities purchase agreement | shares           6,153,847    
Amount of securities purchase agreement         $ 4.0